One of the benefits of going to conferences, besides hearing about the latest data on CLL, is meeting up with good friends in the CLL world. At the iwCLL meeting in Manhattan last May, I met up with a Professor Peter Hillmen from the University of Leeds in the UK, we had the opportunity to talk about minimal residual disease (MRD) in CLL. You can read the article, listen to the interview and read the transcript here: cllsociety.org/2017/08/iwcl....
You might also want to read an article that includes a debate between Dr. Matthew Davids from Dana Farber Cancer Institute and Dr. Richard Furman from Weill Cornell as they take sides on the Role of MRD Negativity in CLL. You can access that article from a link in the above article.
Stay strong
Brian
Unmutated CLL and MRD-
